Caroline P Kerr

8PUBLICATIONS
48CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 08, 2026
In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.

|Apr 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors.

|Jan 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.

Caroline P Kerr, Won Jong Jin, Peng Liu

|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Jul 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor models.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Jan 11, 2024
Comparative Study of the Effect of Radiation Delivered by Lutetium-177 or Actinium-225 on Anti-GD2 Chimeric Antigen Receptor T Cell Viability and Functions.

Quaovi H Sodji, Matthew H Forsberg, Dan Cappabianca

Pageof 2

Frequent Collaborators

5 joint publications

Zachary S Morris

4 joint publications

Wonjong Jin

4 joint publications

Reinier Hernandez

3 joint publications

Paul A Clark